Statistics on Biotechnology Use Results by fields of operation Sector Companies. Results in biotechnology for main variables and branches of activity Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.233 740 405 89 %Companies according to biotechnology used: Genetic code 31,7 41,6 15,1 24,8 %Companies according to biotechnology used: Functional units 38,5 43,6 32,2 25,2 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 22,8 27,7 14,6 19 %Companies according to biotechnology used: Bioprocesses 53,4 43,1 76,8 32,3 %Companies according to biotechnology used: Sub-cellular organisms 8,6 11,9 4,6 0 %Companies according to biotechnology used: Bio-computing 22,3 31 9,6 7,1 %Companies according to biotechnology used: Nanobiotechnology 10,6 13,8 6,9 1,1 %Companies according to biotechnology used: Other 14,2 15,7 7,6 31,7 Companies in which biotechnology activities are: Main and/or exclusive 615 485 113 17 Companies in which biotechnology activities are: A secondary line of business 178 85 79 15 Companies in which biotechnology activities are: A tool necessary for production 440 170 213 57 %Company by field(s) of ultimate application of biotechnology use: Human Health 46,3 63,5 24,4 2,3 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 16,2 17,8 11,8 23,5 %Company by field(s) of ultimate application of biotechnology use: Food products 32 22,4 50 30 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24,6 23,1 18,7 63,4 %Company by field(s) of ultimate application of biotechnology use: Environment 15,5 15 15,5 19,7 %Company by field(s) of ultimate application of biotechnology use: Industry 12,9 13,5 14,1 2,3 Personnel in R&D in biotechnology (no. of persons) 13.444 8.462 4.143 840 Personnel in R&D in biotechnology (no. of persons): Researchers 7.378 5.167 1.974 237 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 6.066 3.295 2.169 603 Personnel in R&D in biotechnology (no. of persons): women 7.501 4.900 2.238 363 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 4.052 2.875 1.070 106 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 3.450 2.025 1.168 257 Personnel in R&D in biotechnology (FTE) 9.401,9 5.991,3 2.869,8 540,9 Personnel in R&D in biotechnology (FTE): Researchers 5.398,3 3.774,1 1.455,1 169,2 Personnel in R&D in biotechnology (FTE): Technicians and assistants 4.003,6 2.217,2 1.414,7 371,7 Personnel in R&D in biotechnology (FTE): women 5.426,2 3.510,7 1.654,8 260,7 Personnel in R&D in biotechnology (FTE): (women) Researchers 3.016,4 2.104,1 830,3 82,1 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 2.409,8 1.406,6 824,5 178,7 Internal expenditure on R&D (thousands of euros) 897.333 545.374 308.398 43.561 1) By nature of the expense: Current expenses 817.409 495.422 283.561 38.426 1.1) Remuneration to researchers 295.705 177.158 109.976 8.570 1.2) Remuneration to technicians and assistants 156.853 84.448 62.043 10.362 1.3) Other current expenses 364.852 233.816 111.542 19.494 2) By nature of the expense: Capital expenses 79.924 49.952 24.837 5.135 2.1) Land and buildings 10.272 5.381 2.529 2.362 2.2) Equipment and instruments 56.609 35.410 19.076 2.123 2.3) Acquisition of specific R&D software 4.839 2.768 1.974 97 2.4) Otros productos de propiedad intelectual específicos para I+D 8.203 6.393 1.257 552 1.1) By origin of the funds: Own funds 613.097 312.617 260.467 40.014 1.2) By origin of the funds: From companies 86.085 76.374 9.711 0 1.3) By origin of the funds: Public Administration funds 92.140 79.925 10.827 1.388 1.4) By origin of the funds: From Universities 853 853 0 0 1.5) By origin of the funds: From non profit private institutions 4.682 4.682 0 0 1.6) By origin of the funds: Foreign funds 100.476 70.924 27.393 2.159 Purchase of R&D services in biotechnology (thousands of euros) 85.011 43.595 40.577 839 Purchase of R&D services in biotechnology (thousands of euros): In Spain 54.243 18.614 34.957 672 Purchase of R&D services in biotechnology (thousands of euros): Abroad 30.768 24.981 5.620 168 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 39,2 49,7 23,8 22,7 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 11,7 11,7 11,5 12 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 12,5 13,6 10,5 12,9 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 10,9 11,8 9,1 11,3 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 14,3 17,6 8,5 13 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 16,5 20,8 9,3 13,6 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 15 17,7 9,7 17 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 36 40 30 32 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 46,7 50,9 39,7 43,2 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19 21,6 14,2 19,5 % Companies that have requested biotechnology patents in Biotechnology 17,3 22,1 10,4 9,4 Number of patents requested 681 528 119 34 % Companies with income of an international origin related to biotechnological activities 23 25,3 22,1 8,6 % Turnover representing income of an international origin related to biotechnological activities 1,6 5,1 1,3 1,2 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 55,9 30,1 65,4 78,2 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 44,1 69,9 34,6 21,8 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 83,9 93,7 79,9 90 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 14,7 2 20 0 % Income of an international origin related with activities according to the classification: Operating source abroad 0,8 2,7 0 0 % Income of an international origin related with activities according to the classification: Other 0,6 1,5 0 10 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute